Carruthers R Michael
SEC CIK 1644467 · EDGAR
BoughtSold
Most active insiders at EWTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Russell Alan J | CSO, Dir | — | $10.25M |
| 2 | Donovan Joanne M. | CMO | — | $4.62M |
| 3 | Edris Badreddin | Dir | — | $3.40M |
| 4 | KOCH KEVIN | Pres, CEO, Dir | — | $785.0K |
| 5 | Derakhshan Behrad | Chief Business Off | — | $223.4K |
| 6 | MOORE JOHN R | GC | — | $219.8K |
| 7 | Fox Jonathan C | Dir | $199.4K | — |
Carruthers R Michael made no open-market trades at EWTX in the last 12 months.
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-14 | 2025-08-12 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $0.00 | +5,781 | 87.6K | +7% | $0 |
| D | 2025-08-14 | 2025-08-12 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | S - Sale+OE | $13.39 | -1,428 | 86.2K | -2% | -$19.1K |
| D | 2025-05-07 | 2025-05-01 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $0.00 | +5,209 | 82.3K | +7% | $0 |
| D | 2025-05-07 | 2025-05-02 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | S - Sale+OE | $16.45 | -1,314 | 81.0K | -2% | -$21.6K |
| D | 2024-10-16 | 2024-10-11 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $0.71 | +70.0K | 76.9K | +1,014% | +$49.7K |
| DM | 2024-10-08 | 2024-10-04 | OKUR | OnKure Therapeutics, Inc. | Carruthers R Michael | Dir | A - Grant | — | +4,939 | 874 | New | — |
| DM | 2024-09-24 | 2024-09-20 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $1.93 | +96.1K | 56.9K | New | +$185.4K |
| DM | 2024-09-24 | 2024-09-20 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | S - Sale+OE | $28.57 | -125.1K | 6,904 | -95% | -$3.57M |
| D | 2024-05-03 | 2024-05-01 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $0.00 | +5,208 | 37.4K | +16% | $0 |
| D | 2024-05-03 | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | S - Sale+OE | $18.91 | -2,157 | 35.2K | -6% | -$40.8K |
| DT | 2024-01-25 | 2024-01-23 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $1.93 | +90.0K | 119.0K | +310% | +$173.7K |
| DT | 2024-01-25 | 2024-01-23 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | S - Sale+OE | $15.78 | -90.0K | 29.0K | -76% | -$1.42M |
| D | 2023-06-26 | 2023-06-22 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $0.71 | +10.0K | 29.0K | +53% | +$7,100 |
| D | 2023-05-03 | 2023-05-01 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $0.00 | +5,208 | 17.5K | +43% | $0 |
| D | 2023-05-03 | 2023-05-02 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | S - Sale+OE | $8.90 | -1,336 | 16.1K | -8% | -$11.9K |
| D | 2022-05-25 | 2022-05-23 | EWTX | Edgewise Therapeutics, Inc. | Carruthers R Michael | CFO | M - OptEx | $0.71 | +9,000 | 12.0K | +300% | +$6,390 |
Purchase Sale Sale after option exercise All abbreviations